Sampre Nutritions (SAMPRE) | Stock Overview & Key Data
Sampre Nutritions Performance Comparison
Stock Range
Today's Range
Low: ₹60.49
High: ₹60.76
on August 8, 2025
52 Week Range
Low: ₹20.90
High: ₹101.17
on March 28, 2025
on November 11, 2024
All-Time High: ₹296.35 on October 17, 2022
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.3B
EPS
-5.20
P/E Ratio (TTM)
151.31
Forward P/E
N/A
P/B Ratio
1.40
PEG Ratio
-0.13
Div. Yield
N/A
ROE
-8.44%
Beta
-0.336
Debt to Equity
18.60
Financial Highlights
Profitability
Gross Margin
63.47%
Operating Margin
9.03%
Profit Margin
-22.45%
Returns and Earnings
Return on Assets (TTM)
-6.65%
Return on Equity (TTM)
-8.44%
EBITDA
INR-33.8M
Net Income (TTM)
INR-70.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR17.52
Quarterly Revenue Growth (YoY)
140.60%
Quarterly Earnings Growth (YoY)
615.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Sampre Nutritions SAMPRE | 1.28B Small-cap | 10.37% | 56.84% | 152.01% | 63.64% | -3.40% | -20.73% | -19.42% | 334.00% |
| Balrampur Chini BALRAMCHIN | 110.69B Mid-cap | -3.19% | -8.71% | 0.97% | 18.77% | -0.01% | 11.04% | 60.68% | 283.40% |
| Triveni Engineering TRIVENI | 75.19B Mid-cap | -1.12% | -8.85% | -17.68% | -11.50% | -27.18% | -11.27% | 50.65% | 343.42% |
| Bannari Amman Sugars BANARISUG | 47.26B Small-cap | -0.85% | -3.57% | -5.79% | 4.70% | 2.96% | 18.96% | 38.62% | 187.73% |
| Bajaj Hindusthan BAJAJHIND | 29.06B Small-cap | -1.04% | -21.94% | 21.34% | -12.91% | -27.09% | -42.47% | 112.52% | 288.72% |
| Dalmia Bharat Sugar DALMIASUG | 28.94B Small-cap | -4.69% | -10.27% | -4.07% | 3.26% | -5.21% | -9.24% | 4.52% | 161.79% |
Ownership & Short Interest
Insider Ownership
52.55%
Institutional Ownership
10.03%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
117K
Average 90-Day Volume
122K
Sampre Nutritions Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sampre Nutritions would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SAMPRE's 52-week high and low?
- In the last 52 weeks, Sampre Nutritions reached a high of ₹101.17 (on November 11, 2024) and a low of ₹20.90 (on March 28, 2025).
- What is the market cap and P/E ratio for SAMPRE?
- Curious about Sampre Nutritions's size and valuation? Its market capitalization stands at 1.28B. When it comes to valuation, the P/E ratio (trailing twelve months) is 151.31, and the forward P/E (looking ahead) is N/A.
- Does SAMPRE pay dividends? If so, what's the yield?
- As for dividends, Sampre Nutritions isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Sampre Nutritions's main competitors or similar companies to consider before investing?
When looking at Sampre Nutritions, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Balrampur Chini
BALRAMCHIN110.69B Consumer Defensive Confectioners 11.04% 60.68% Triveni Engineering
TRIVENI75.19B Consumer Defensive Confectioners -11.27% 50.65% Bannari Amman Sugars
BANARISUG47.26B Consumer Defensive Confectioners 18.96% 38.62% Bajaj Hindusthan
BAJAJHIND29.06B Consumer Defensive Confectioners -42.47% 112.52% Dalmia Bharat Sugar
DALMIASUG28.94B Consumer Defensive Confectioners -9.24% 4.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sampre Nutritions Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Sampre Nutritions's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -8.44%, the Debt to Equity ratio from the most recent quarter is 18.60, and its Gross Profit Margin stands at 63.47%.
- What is the recent revenue and earnings growth for SAMPRE?
- Looking at Sampre Nutritions's growth, its revenue over the trailing twelve months (TTM) was INR315M. Compared to the same quarter last year (YoY), quarterly revenue grew by 140.60%, and quarterly earnings saw a YoY growth of 615.50%.
- How much of SAMPRE stock is held by insiders and institutions?
- Wondering who owns Sampre Nutritions stock? Company insiders (like executives and directors) hold about 52.55% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 10.03%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.